The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Mitogen-Activated Protein Kinases and Retinal Ischemia
Abstract
purpose. Mitogen-activated protein kinases (MAPKs), consisting of three major enzymes—extracellular signal-regulated kinase (ERK), p38, and c-jun N-terminal kinase (JNK)—couple cell-surface receptors to critical regulatory targets and gene transcription. We hypothesized that MAPKs are differentially expressed and have distinct functions after retinal ischemia. methods. Rats were subjected to retinal ischemia by elevation of intraocular pressure. Changes in MAPK expression were examined by Western blot of whole retinal homogenates and by immunohistochemistry of retinal cryosections. Phosphorylated (activated) ERK, p38, and JNK proteins were localized by fluorescent double labeling. The functional significance of activated MAPKs was assessed using pharmacological antagonists. Specific MAPK blockade was documented by kinase assay and immunohistochemistry for phosphorylated target proteins. The outcome after ischemia was examined with electroretinography (ERG), by measuring retinal cell layer thickness in paraffin-embedded sections, and by TUNEL staining on retinal cryosections. Data were analyzed using ANOVA and post hoc t-test, with P < 0.05 considered significant. results. Expression of phosphorylated JNK and p38 increased significantly after ischemia and followed a specific time course, beginning at 1 hour, and persisting up to 1 week later. JNK and p38 were expressed in the nuclei of ganglion and amacrine cells, the outer plexiform layer, the nerve fiber layer, and the axonal terminals of bipolar cells. Phosphorylated ERK was expressed in Müller cells, peaking at 1 to 6 hours after ischemia. Blocking activation of p38 or ERK significantly improved recovery of the ERG b-wave after ischemia, dramatically decreased thinning of the inner nuclear layers, and decreased the percentage of TUNEL-positive cells. conclusions. The MAPKs each demonstrate a specific cellular distribution after ischemia, and ERK and p38 are linked to apoptosis. Blockade of p38 or ERK provides significant protection from ischemic damage, suggesting a novel therapeutic role for MAPK inhibition in neuroprotection.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“JNK and p38 phosphorylation is increased after retinal ischemia, mainly in amacrine, ganglion and bipolar cells while ERK is activated in MG cells [ 25 ].”
From MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges (2023) · cites this paper as [25]
In the citing paper
“Multiple MEK pathways have been also reported to be involved in retinal ischemia, with each demonstrating a specific pattern of cellular expression, while the blockade of p38 or ERK can provide significant protection from ischemic damage [ 25 ].”
From MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges (2023) · cites this paper as [25]
In the citing paper
“Specific blockage of ERK and p38 phosphorylation, but not of JNK, prevents ischemia-induced apoptosis and improves retinal function in a rat model [ 25 ].”
From MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges (2023) · cites this paper as [25]
In the citing paper
“Although inhibition of p38 or ERK has been shown to confer significant protection from ischemic damage as assessed by retinal cell layer thickness and apoptosis measurement [ 25 ]”
From MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges (2023) · cites this paper as [25]
Citations
Cites
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.
Gavrieli, Y., Sherman, Y., & Ben-Sasson, S. A. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.3.493 · Cited by 9,444 · cited 2×
“TdT-mediated dUTP-biotin nick-end labeling (TUNEL) staining was performed on 10- m frozen retinal sections with a TdT-fluorescein fragmentation detection kit (FragEL DNA; Oncogene, La Jolla, CA), with procedures modified from Gavrieli et al.(28) and as we described previously.”
MethodMammalian MAP kinase signalling cascades
Chang, L., & Karin, M. (2001) · Nature · doi:10.1038/35065000 · Cited by 5,111 · cited 2×
“03-0451 Mitogen-activated protein kinases (MAPKs) couple cell-surface receptors to critical regulatory targets and gene transcription within cells, are responsive to chemical and physical stresses, and play a key role in cell survival and adaptation.(1) MAPKs are activated by G-protein–linked receptors.”
BackgroundAlessi, D. R., Cuenda, A., Cohen, P., Dudley, D. T., & Saltiel, A. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.46.27489 · Cited by 3,393 · cited 2×
“It has approximately 100-fold greater affinity for MEK than the other commonly used MEK inhibitor, PD098059.(32,33) U0126 (26 mM in 1% DMSO) was injected intraperitoneally (2000 g/kg), 1 hour before ischemia.”
MethodSP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase
Bennett, B. L., Sasaki, D. T., Murray, B. W., O'Leary, E. C., Sakata, S. T., Xu, W., Leisten, J. C., Motiwala, A., Pierce, S., Satoh, Y., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251194298 · Cited by 2,558 · cited 4×
“SP600125 is a cell-permeable, reversible, and highly specific inhibitor of JNK.(37) We prepared SP600125 as a 100-mM stock solution in DMSO and injected 2 L of a 1-mM solution (1% DMSO) before and after ischemia, resulting in an estimated vitreous concentration of 63 M after each injection.”
MethodInfluentialSweatt, J. D. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00054.x · Cited by 1,131
Serine/Threonine Protein Kinases and Apoptosis
Cross, T. G., Scheel-Toellner, D., Henriquez, N. V., Deacon, E., Salmon, M., & Lord, J. M. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4836 · Cited by 690 · cited 1×
“The MAPKs, modulators of transcription, affect the rate of apoptosis through mechanisms that probably modify gene expression.(5) However, it has not been determined whether MAPKs have a functional role in retinal ischemia or in the induction of apoptosis after ischemia.”
BackgroundCell-Permeable Peptide Inhibitors of JNK
Bonny, C., Oberson, A., Negri, S., Sauser, C., & Schorderet, D. F. (2001) · Diabetes · doi:10.2337/diabetes.50.1.77 · Cited by 571
Activation of Trk neurotrophin receptors in the absence of neurotrophins
Lee, F. S., & Chao, M. V. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061020198 · Cited by 482 · cited 1×
“MAPKs are activated by G-protein–linked receptors.(2,3) Their expression is influenced by protein kinases A and C, receptor tyrosine kinases, cytokines, and other stress molecules.”
BackgroundIschemic Preconditioning: From Adenosine Receptor to KATP Channel
Cohen, M. V., Baines, C. P., & Downey, J. M. (2000) · Annual Review of Physiology · doi:10.1146/annurev.physiol.62.1.79 · Cited by 475 · cited 1×
“Moreover, under some circumstances, such as in the myocardium, p38 and JNK may actually play an apparently paradoxical, but protective, role by stimulating ischemic preconditioning protection.(12,13) ERK, JNK, and p38 expression increased after focal and global cerebral ischemia in rats and gerbils, each demonstrating…”
BackgroundMEK1 protein kinase inhibition protects against damage resulting from focal cerebral ischemia
Alessandrini, A., Namura, S., Moskowitz, M. A., & Bonventre, J. V. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12866 · Cited by 464 · cited 2×
“When phosphorylated, the vesicles dissociate and release neurotransmitters.(17) Excessive release of glutamate and aspartate leads to neuronal damage after ischemia.”
BackgroundResult
Cited by
Mesenchymal stem cell-derived extracellular vesicles and retinal ischemia-reperfusion
Mathew, B., Ravindran, S., Liu, X., Torres, L., Chennakesavalu, M., Huang, C.-C., Feng, L., Zelka, R., Lopez, J., Sharma, M., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.01.016 · Cited by 313
Self-citationThe RAGE Axis in Early Diabetic Retinopathy
Barile, G. R., Pachydaki, S. I., Tari, S. R., Lee, S. E., Donmoyer, C. M., Ma, W., Rong, L. L., Buciarelli, L. G., Wendt, T., Ho¨rig, H., et al. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-1409 · Cited by 200
King, R. E., Kent, K. D., & Bomser, J. A. (2005) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2004.11.003 · Cited by 192
From oxygen to erythropoietin: Relevance of hypoxia for retinal development, health and disease
Caprara, C., & Grimm, C. (2012) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2011.11.003 · Cited by 176
Effects of p38 MAPK Inhibition on Early Stages of Diabetic Retinopathy and Sensory Nerve Function
Du, Y., Tang, J., Li, G., Berti-Mattera, L., Lee, C. A., Bartkowski, D., Gale, D., Monahan, J., Niesman, M. R., Alton, G., et al. (2010) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.09-3674 · Cited by 136
“Suppression of p38 MAPK has been found to inhibit acute lung inflammation,(8,9) ischemia/ reperfusion,(10) rheumatoid arthritis, Alzheimer’s disease, and inflammatory bowel disease, as well as in ocular ischemia– reperfusion injury.(14) The demonstrated role of p38 MAPK in the development of inflammation in a variety…”
Background
Metadata
- Authors
- Roth, S., Shaikh, A. R., Hennelly, M. M., Li, Q., Bindokas, V., & Graham, C. E.
- Affiliations
- University of Chicago (US)
- From the Departments of Anesthesia and Critical Care,
- Neurobiology, and
- Venue
- Investigative Opthalmology & Visual Science
- Published
- 2003-12-01
- Volume
- 44
- Issue
- 12
- Pages
- 5383
- ISSN
- 0146-0404 (ISSN-L)
- 1552-5783
- OpenAlex
- W2130729942
- Cited by
- 117
- References
- 56
- Citations by year
- 2026: 3 · 2024: 1 · 2023: 9 · 2022: 3 · 2021: 2 · 2020: 4 · 2019: 7 · 2018: 4 · 2017: 5 · 2016: 4 · 2015: 10 · 2014: 7 · 2013: 5 · 2012: 4
- FWCI
- 1.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Investigative Ophthalmology & Visual Science (publishedVersion)
- Funders
- National Eye Institute (EY10343)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Keywords
- mitogen-activated protein kinase, retinal ischemia, p38 MAPK, ERK, JNK, MAPK phosphorylation, MAPK inhibition, neuroprotection, apoptosis, Müller cells, retinal ganglion cells, amacrine cells, bipolar cells, intraocular pressure elevation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mitogen-Activated Protein Kinases and Retinal Ischemia. https://app.cochat.ai/papers/10.1167/iovs.03-0451
- The paper
- Roth, S., Shaikh, A. R., Hennelly, M. M., Li, Q., Bindokas, V., & Graham, C. E. (2003). Mitogen-Activated Protein Kinases and Retinal Ischemia. Investigative Opthalmology & Visual Science. https://doi.org/10.1167/iovs.03-0451
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.